Saliva - The defender of the oral cavity

Oral Diseases

Volumn 8, Issue 1, 2002, Pages 12-22

  Nieuw Amerongen, A V ^a   Veerman, E C I ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLUTININ; AMYLASE; CALPROTECTIN; CHITINASE; CHROMOGRANIN A; CYSTATIN; CYSTEINE PROTEINASE INHIBITOR; DEFENSIN; EXTRAPAROTID GLYCOPROTEIN; HISTATIN; LACTOFERRIN; LACTOPEROXIDASE; LYSOZYME; MUCIN; PROTEINASE; SALIVA PROTEIN; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; VON EBNER GLAND PROTEIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; CELL GROWTH; HUMAN; MOLECULAR WEIGHT; MOUSE; MOUTH CAVITY; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION; SALIVA; SALIVATION; TASTE;

ANIMALS; HUMANS; IMMUNITY, NATURAL; MOUTH; SALIVA; SALIVARY PROTEINS;

EID: 0036119654     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1601-0825.2002.1o816.x     Document Type: Article

References (117)

1. Functional cavity dimensions of tear lipocalins
2. Isolation from a human seminal vesicle library of the cDNA for gp17, a CD4 binding factor
3. The effects of adrenergic agonists and antagonists on cysteine-proteinase inhibitor (cystatin) in rat saliva
4. Identification of the bactericidal domain of lactoferrin
5. Killing of Candida albicans by lactoferricin-B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin
6. Detection of binding of denatured salivary alpha-amylase to Streptococcus sanguis
7. Interaction of a salivary mucin-secretory immunoglobulin A complex with mucosal pathogens
8. MUC7 gene expression and genetic polymorphism
9. Immunohistochemical detection of salivary agglutinin/gp-340 in different human salivary glands
10. Inhibition of the growth and cysteine proteinase activity of Porphyromonas gingivalis by human salivary cystatin S and chicken cystatin
11. Cystatins and cystatin-derived peptides have antibacterial activity against the pathogen Porphyromonas gingivalis
12. Molecular cloning, sequence, and specificity of expression of the gene encoding the low molecular weight human salivary mucin (MUC7)
13. Detection and quantification of MUC7 in submandibular, sublingual, palatine, and labial saliva by anti-peptide anti-serum
14. Distinct populations of high-Mr mucins secreted by different human salivary glands discriminated by density-gradient electrophoresis
15. Salivary MUC5B-mediated adherence (ex vivo) of Helicobacter pylori during acute stress
16. Differential effects of active versus passive coping on secretory immunity
17. Biosynthesis and immunobiochemical characterization of gp17/GCDFP-15
18. A novel aspartyl proteinase from apocrine epithelia and breast tumors
19. Monoclonal antibodies against high-molecular weight agglutinin block adherence to experimental pellicles on hydroxyapatite and aggregation of Streptococcus mutans
20. Isoproterenol-induced expression of the cystatin S gene in submandibular glands of parasympathectomized rats
21. Defensin antimicrobial peptides in the oral cavity
22. Human gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains resulting in a super-repeat - Structural evidence for a 11p15.5 gene family
23. Recombinant human lactoferrin is effective in the treatment of Helicobacter felis-infected mice
24. Purification and characterization of Eikenella corrodens aggregating factor from submandibular-sublingual saliva
25. Candidacidal activity of salivary histatins
26. Characterization of a salivary agglutinin reacting with a serotype c strain of Streptococcus mutans
27. The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6
28. Porcine VEG proteins and tear prealbumins
29. Potent inhibition of CD4/TCR-mediated T cell apoptosis by a CD4-binding glycoprotein secreted from breast tumor and seminal vesicle cells
30. Mucin genes expressed by human female reproductive tract epithelia
31. Interaction of the salivary low-molecular-weight mucin (MG2) with Actinobacillus actinomycetemcomitans
32. Cationic amphipathic peptides, derived from bovine and human lactoferrins, with antimicrobial activity against oral pathogens
33. Salivary lactoferin and low-Mr mucin MG2 in Actinobacillus actinomycetemcomitans-associated periodontitis
34. Salivary histatin 5 is an inhibitor of both host and bacterial enzymes implicated in periodontal disease
35. Is salivary histatin 5 a metallopeptide?
36. Structural basis for different inhibitory specificities of human cystatins C and D
37. Peptide antibiotics
38. Mucoid Pseudomonas aeruginosa, TNF-α, and IL-1β, but not IL-6, induce human α-defensin-2 in respiratory epithelia
39. Collagenase activity and tissue inhibitor of metalloproteinases-1 (TIMP-1) content in human whole saliva from clinically healthy and periodontally diseased subjects
40. The cellular target of histatin 5 on Candida albicans is the energized mitochondrion
41. The effects of histatin-derived basic antimicrobial peptides on oral biofilms
42. Characterization of histatin 5 with respect to amphipathicity, hydrophobicity, and effects on cell and mitochondrial membrane integrity excludes a candidacidal mechanism of pore formation
43. Cystatins S and C in human whole saliva and in glandular salivas inperiodontal health and disease
44. Cystatins in health and disease
45. Cloning of gp-340, a putative opsonin receptor for lung surfactant protein D
46. Histatin 5 inhibits inflammatory cytokine induction from human gingival fibroblasts by Porphyromonas gingivalis
47. Human salivary mucin MG1 selectively forms heterotypic complexes with amylase, proline-rich proteins, statherin, and histatins
48. Adsorption of human salivary proteins to hydroxyapatite - A comparison between whole saliva and glandular salivary secretions
49. Cytokine-inducing activity of family 2 cystatins
50. Genetic polymorphism of MUC7: Allele frequencies and association with asthma
51. A comparison of salivary calprotectin levels in subjects with and without oral candidiasis
52. Inducible expression of human β-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: Multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier
53. Bactericidal activity of human lysozyme, muramidase-inactive lysozyme, and cationic polypeptides against Streptococcus sanguis and Streptococcus faecalis: Inhibition by chitin oligosaccharides
54. Salivary agglutinin-mediated adherence of Streptococcus mutans to early plaque bacteria
55. Human tear lipocalin acts as as oxidative stress-induced scavenger of potentially harmful lipid peroxidation products in a cell culture system
56. Structural aspects of salivary glycoproteins
57. A role for Lewis a antigens on salivary agglutinin in binding to Streptococcus mutans
58. Human salivary agglutinin binds to lung surfactant protein-D and is identical to scavenger receptor protein gp-340
59. Isolation of human salivary mucin MG2 by a novel method and characterization of its interactions with oral bacteria
60. The recombinant N-terminal region of human salivary mucin MG2 (MUC7) contains a binding domain for oral Streptococci and exhibits candidacidal activity
61. Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A
62. Candidacidal activities of human lactoferrin peptides derived from the N terminus
63. Growth-inhibitory and bactericidal effects of human parotid salivary histidine-rich polypeptides on Streptococcus mutans
64. An in situ microbiological study of the early colonisation of human enamel surfaces
65. Secretory leukocyte protease inhibitor: A human saliva protein exhibiting anti-human immunodeficiency virus I activity in vitro
66. Isolation and physical characterization of the MUC7 (MG2) mucin from saliva: Evidence for self association
67. 2+ ions selectively induce antimicrobial salivary peptide histatin-5 to fuse negatively charged vesicles. Identification and characterization of a zinc-binding motif present in the functional domain
68. The relative contribution of different salivary glands to the blood group activity of whole saliva in humans
69. DMBT! encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer
70. Role of type 1 fimbriae in the adhesion of Escherichia coli to salivary mucin and secretory immunoglobulin A
71. Multiple functions of tissue inhibitors of metalloproteinases (TIMPs): New aspects in hematopoiesis
72. Adherence of oral Streptococci to salivary glycoproteins
73. Salivary chromogranin A as an index of psychosomatic stress response
74. Identification of a major human high molecular weight salivary mucin (MG1) as tracheobronchial mucin MUC5B
75. Role of mucins from human whole saliva in the protection of tooth enamel against demineralization in vitro
76. Salivary mucins: Protective functions in relation to their diversity
77. The fungicidal effect of human lactoferrin on Candida albicans and Candida krusei
78. Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungicidal effects on Candida albicans
79. Quantification of human myeloperoxidase in oral fluids
80. Human low-molecular weight salivary mucin expresses the sialyl Lewis (X) determinant and has L-selectin ligand activity
81. Salivary agglutinin which binds Streptococcus mutans and Helicobacter pylori is the lung scavenger receptor cysteine-rich protein gp-340
82. Isolation and characterization of three non-mucinous human salivary proteins with affinity for hydroxyapatite
83. Low-molecular-mass human salivary mucin MG2: Structure and binding of Pseudomonas aeruginosa
84. Phage display reveals a novel interaction of human tear lipocalin and thioredoxin which is relevant for ligand binding
85. Cumulative correlations of lysozyme, lactoferrin, peroxidase, S-IgA, amylase, and total protein concentrations, with adherence of oral viridans streptococci to microplates coated with human saliva
86. Effects of histatin 5 and derived peptides on Candida albicans
87. Salivary amylase promotes adhesion of oral Streptococci to hydroxyapatite
88. Identity of human extra parotid glycoprotein (EP-GP) with secretory actib binding protein (SABP) and its biological properties
89. EP-GP and the lipocalin VEGh, two different human salivary 20-kDa proteins
90. Biochemical composition of human saliva in relation to other mucosal fluids
91. In vivo binding of the salivary glycoprotein EP-GP (identical to GCDFP-15) to oral and non-oral bacteria detection and identification of EP-GP binding species
92. Secretory IgA, free secretory component and IgD in saliva of newborn infants
93. MUC5B and MUC7 are differentially expressed in mucous and serous cells of submucosal glands in human bronchial airways
94. Properties of cysteine-containing phosphoproteins from human submandibular-sublingual saliva
95. Salivary concentration of secretory leukocyte protease inhibitor, an antimicrobial protein, is decreased with advanced age
96. In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1
97. Fungicidal effect of human lactoferrin against
98. Salivary levels of immunoglobulin A in triathletes
99. Salivary calprotectin levels are raised in patients with oral candidiasis or Sjögren's syndrome but decreased by HIV infection
100. In defense of the oral cavity: Structure, biosynthesis, and function of salivary mucins
101. Gustin from human parotid saliva is carbonic anhydrase VI
102. Leukocyte myeloperoxidase and salivary lactoperoxidase - Identification and quantification in human mixed saliva
103. Salivary mucin MG1 is comprised almost entirely of different glycosylated forms of the MUC5B gene product
104. Structural relationships between human salivary histatins
105. Differential effect toward inhibition of papain and cathepsin C by recombinant human salivary cystatin SN and its variants produced by baculovirus system
106. Intra- and interspecies signaling between Streptococcus pyogenes mediated by SalA and SalA1 lantibiotic peptides
107. The salivary lipocalin Von Ebner's gland protein is a cysteine proteinase inhibitor
108. Antimicrobial peptides: Properties and applicability
109. MUC5B is the prominent mucin in human gallbladder and is also expressed in a subset of colonic goblet cells
110. Chitinase in whole human salivas and in whole saliva of patients with periodontal inflammation
111. Effect of periodontal treatment on the activity of chitinase in whole saliva of periodontitis patients
112. Isolation of different high-Mr mucin species from human whole saliva
113. Binding of human high-molecular-weight salivary mucin (MG1) to Haemophilus parainfluenzae
114. Sulfated glycans on oral mucin as receptors for Helicobacter pylori
115. Human glandular salivas: Their separate collection and analysis
116. Identification of histatins as tannin-binding proteins in human saliva
117. Endonuclease activity in lipocalins